{"database":"MetabolomicsWorkbench","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Other":["http://www.metabolomicsworkbench.org/rest/study/study_id/ST000423/mwtab"]},"type":"primary"},"statusCodeValue":200,"statusCode":"OK"}],"scores":null,"additional":{"omics_type":["Metabolomics"],"technology_type":["Mass Spectrometry","ESI"],"species":["Mus Musculus"],"full_dataset_link":["http://www.metabolomicsworkbench.org/data/DRCCMetadata.php?Mode=Study&StudyID=ST000423"],"study_factor":["Treatment:Resident macrophage","Treatment:Bone marrow macrophage"],"submitter_affiliation":["University of California, Davis"],"tissue":["Cells"],"sample_protocol":["UPLC POSITIVE ION MODE. UPLC NEGATIVE ION MODE."],"repository":["MetabolomicsWorkbench"],"metabolite_name":["PE (p-36:4) or PE (o-36:5)","PE (38:4)","TG (54:1)","PC (38:4)","SM (d42:1)","PC (36:2)","PE (36:2)","PC (34:0)","PC (p-34:0) or PC (o-34:1)","PC (40:8)","TG (48:1)","TG (60:2)","SM (d36:1)","PE (p-38:4) or PE (o-38:5)","TG (56:2)","PC (p-38:3) or PC (o-38:4)","PE (p-40:5) or PE (o-40:6)","PC (p-40:4) or PC (o-40:5)","TG (58:4)","TG (51:1)","PC (38:5)","SM (d42:2)","PC (36:3)","PE (34:1)","Ceramide (d34:1)","PC (p-38:5) or PC (o-38:6)","Ceramide (d40:1)","PE (p-40:7) or PE (o-40:8)","PC (34:1)","PC (p-40:6) or PC (o-40:7)","SM (d39:1)","PC (p-42:4) or PC (o-42:5)","TG (48:0)","SM (d34:1)","TG (56:1)","SM (d40:1)","GlcCer (d41:1)","PE (36:4)","SM (d42:3)","PE (38:6)","Gal-Gal-Cer(d18:1/16:0) or Lactosylceramide(d18:1/16:0)","PC (38:2)","Ceramide (d34:0)","PC (33:1)","PC (40:6)","Ceramide (d42:2)","TG (14:0/14:0/14:0)","FA (20:1) (eicosenoic acid)","SM (d34:2)","TG (52:4)","TG (58:2)","PC (28:0)","TG (54:6)","PE (p-38:5) or PE (o-38:6)","TG (50:2)","Ceramide (d18:1/23:0)","PC (p-38:4) or PC (o-38:5)","PE (p-40:6) or PE (o-40:7)","Cholesterol","GlcCer(d14:1(4E)/20:0(2OH))","PC (p-42:3) or PC (o-42:4)","Ceramide (d36:1)","PC (38:3)","PC (36:1)","PE (p-36:2) or PE (o-36:3)","PC (p-36:1) or PC (o-36:2)","Ceramide (d42:1)","PC (31:0)","PC (40:7)","TG (58:1)","PC (p-42:5) or PC (o-42:6)","FA (22:6) (docosahexaenoic acid)","PC (o-32:0)","TG (52:3)","SM (d43:2)","TG (50:1)","PC (34:4)","PE (p-36:5) or PE (o-36:6)","Ceramide (d33:1)","PC (40:4)","PC (35:1)","PE (p-40:4) or PE (o-40:5)","PC (30:0)","PC (42:6)","SM (d32:1)","TG (54:4)","TG (56:6)","GlcCer (d42:1)","TG (52:2)","PE (p-36:1) or PE (o-36:2)","TG (50:0)","SM (d41:1)","LPC (16:0)","PC (33:0)","PC (40:5)","PC (30:1)","TG (58:8)","PC (42:7)","TG (54:3)","FA (20:4) (arachidonic acid)","TG (56:5)","TG (52:1)","FA (24:0) (lignoceric acid)","Ceramide (d38:1)","GlcCer (d42:2)","PC (o-34:0)","PC (p-36:3) or PC (o-36:4)","PC (38:6)","SM (d41:2)","LPC (18:1)","CE (18:1)","PC (36:4)","PC (34:2)","PC (p-36:4) or PC (o-36:5)","PE (p-34:1) or PE (o-34:2)","Ceramide (d41:1)","PC (32:0)","PC (p-40:3) or PC (o-40:4)","SM (d38:1)","TG (49:0)","PE (p-34:2) or PE (o-34:3)","PC (p-34:1) or PC (o-34:2)","TG (54:2)","TG (56:4)","TG (52:0)","GlcCer (d40:1)","FA (24:1) (nervonic acid)","LPC (18:0)","TG (46:0)","PC (36:5)","PC (34:3)","FA (22:0) (behenic acid)","CE (22:6)","PC (32:1)","TG (58:6)","PC (42:5)","TG (48:2)","CE (20:4)","SM (d33:1)"],"data_protocol":[""],"name_synonyms":["development, Haemobartonella, PPLO, postnatal development., Asterococcus <mycoplasmas>, growth pattern, Pleuropneumonia-Like Organisms, non-developmental growth, Bovimyces, postnatal growth, Mycoplasma putrefaciens, Borrelomyces, growth and development, Eperythrozoon, growth, Pleuropneumonia Like Organisms, Pleuropneumonia, Asteromyces <mycoplasmas>"],"sample_synonyms":["iones., Ionen, ion, Ion, ions, iones"],"additional_accession":[]},"is_claimable":false,"name":"Differences in mycoplasma growth due to different mediums","description":null,"dates":{"publication":""},"accession":"ST000423","cross_references":{"TAXONOMY":["10090"]}}